The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients

The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients

Neuroendocrine markers, which could indicate for aggressive variants of prostate cancer and Ki67 (a well-known marker in oncology for defining tumor proliferation), have already been associated with clinical outcome in prostate cancer. The aim of this study was to investigate the prognostic value of...

Full description

Bibliographic Details
Main Authors: Pascale Mariarosa, Aversa Cinzia, Barbazza Renzo, Marongiu Barbara, Siracusano Salvatore, Stoffel Flavio, Sulfaro Sando, Roggero Enrico, Bonin Serena, Stanta Giorgio
Format: Article
Language:English
Published: Sciendo 2016-09-01
Series:Radiology and Oncology
Subjects:
primary prostate cancer
prognosis
ki67
nse
Online Access:https://doi.org/10.1515/raon-2016-0033
Description
Summary:Neuroendocrine markers, which could indicate for aggressive variants of prostate cancer and Ki67 (a well-known marker in oncology for defining tumor proliferation), have already been associated with clinical outcome in prostate cancer. The aim of this study was to investigate the prognostic value of those markers in primary prostate cancer patients.
ISSN:1581-3207

Similar Items